Pharmabiz13h
Innocan Pharma submits INAD application to US FDA's Center for Veterinary Medicine for LPT-CBD product
Innocan Pharma submits INAD application to US FDA's Center for Veterinary Medicine for LPT-CBD product: Herzliya, Israel Tuesday, July 30, 2024, 16:00 Hrs [IST] Innocan Pharma Cor ...
Pharmabiz18h
EMA committee recommends approval of Astellas’ zolbetuximab in combo with chemotherapy to treat advanced gastric and GEJ cancer
EMA committee recommends approval of Astellas’ zolbetuximab in combo with chemotherapy to treat advanced gastric and GEJ cancer: Tokyo Tuesday, July 30, 2024, 11:00 Hrs [IST] As ...
Pharmabiz12h
US FDA approves Luye Pharma’s Erzofri ER injectable suspension to treat schizophrenia and schizoaffective disorder
US FDA approves Luye Pharma’s Erzofri ER injectable suspension to treat schizophrenia and schizoaffective disorder: Princeton, New Jersey Tuesday, July 30, 2024, 17:00 Hrs [IST] ...
Pharmabiz11h
BerGenBio announces selection of 2nd dose in phase 2a first line STK11m non-small lung cancer trial
BerGenBio announces selection of 2nd dose in phase 2a first line STK11m non-small lung cancer trial: Bergen, Norway Tuesday, July 30, 2024, 18:00 Hrs [IST] BerGenBio ASA, a clinic ...
Pharmabiz12h
OneSource & Bhami’s Research Lab ink licensing pact for technology to deliver high-concentration biologics subcutaneously
OneSource & Bhami’s Research Lab ink licensing pact for technology to deliver high-concentration biologics subcutaneously: Our Bureau, Bengaluru Tuesday, July 30, 2024, 16:50 Hr ...
Pharmabiz11h
Biocon Foundation with IISc lead expert for phase 1 of the project the AI-Center of Excellence
Our Bureau, Bengaluru Tuesday, July 30, 2024, 17:45 Hrs [IST] ...
Pharmabiz15h
GSK’s RSV vaccine, Arexvy receives positive EMA CHMP opinion for adults aged 50-59 at increased risk for RSV disease
GSK’s RSV vaccine, Arexvy receives positive EMA CHMP opinion for adults aged 50-59 at increased risk for RSV disease: London, UK Tuesday, July 30, 2024, 14:00 Hrs [IST] GSK plc ...
Pharmabiz14h
Boehringer Ingelheim announces EMA’s CHMP recommends approval of new indication of Spevigo for prevention of GPP flares
Boehringer Ingelheim announces EMA’s CHMP recommends approval of new indication of Spevigo for prevention of GPP flares: Ingelheim, Germany Tuesday, July 30, 2024, 15:00 Hrs [IS ...
Pharmabiz12h
Tata Memorial study finds nimotuzumab significantly increases survival in head and neck cancer
Tata Memorial study finds nimotuzumab significantly increases survival in head and neck cancer: Our Bureau, Mumbai Tuesday, July 30, 2024, 17:10 Hrs [IST] A study conducted by Tat ...
Pharmabiz12h
Molbio and Directorate of Health Services sign MoU to enhance healthcare services in Goa
Molbio and Directorate of Health Services sign MoU to enhance healthcare services in Goa: Our Bureau, Mumbai Tuesday, July 30, 2024, 16:40 Hrs [IST] Molbio Diagnostics Private Ltd ...
Pharmabiz19h
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
GSK and Flagship Pioneering partner to discover novel medicines and vaccines: London Tuesday, July 30, 2024, 10:00 Hrs [IST] GSK plc and Flagship Pioneering (Flagship), the biopla ...
Pharmabiz20h
2nd Annual Pharma Impurities Conclave to be held in Hyderabad from Sept 12 to 13
Pharma Impurities Conclave to be held in Hyderabad from Sept 12 to 13: Our Bureau, Mumbai Tuesday, July 30, 2024, 09:00 Hrs [IST] The challenge of managing and mitigati ...